Tell you basically information about the Therapeutic antibody engineering


Posted April 21, 2015 by PressR

Antibody engineering refer to the using of recombinant DNA and protein engineering techniques to process and reassemble the antibody gene and then express the antibody molecule by transfecting the antibody gene to the suitable recipient cells.

 
America-Antibody engineering refer to the using of recombinant DNA and protein engineering techniques to process and reassemble the antibody gene and then express the antibody molecule by transfecting the antibody gene to the suitable recipient cells. Those antibody molecules which have been reengineered by the means of Clinical Epigenetics is the new antibody molecule according to designation of human and people may retain or increase the structures with specificity and biological activity to achieve the medical demand so this kind of antibody is more valuable than the natural antibodies.

By the introduction of famous Therapeutic antibody engineering service supplier www.chempartner.com , the biotechnology and information technology will provide a strong impetus for the development of the global economy. The antibody engineering technology is becoming more and more perfectly with the development of modern biotechnology and continuous improvement of related technical areas. In the future, this area must be the main force of the biotechnology industry especially it will play an important role in the field of bio-pharmaceutical technology.

Compared with the monoclonal antibody, the Therapeutic antibody engineering has the following advantages.

First, through the transformation of genetic engineering techniques, it can reduce or even eliminate the body¡¯s rejection to the antibody.

Secondly, the molecular for the recombinant antibody is very small and it will help to reduce the murine antibodies and then it will be more conducive to penetrate the vessel wall.

Thirdly, according to need of treatment, people could easily produce new antibody by the Antibody-drug conjugates method.

Fourthly, by the using of a variety of expressions from prokaryotic cells, eukaryotic cells and plants, people could produce a large number of the antibody molecule and then significantly reduce production costs.

About ChemPartner
We are proud to introduce to you ChemPartner, an evolution from the pure chemistry service provider that originated 12 years ago, into the full-service LifeScience CRO with deep and extensive pharmaceutical research understanding at all levels.

Contact:
Website: http://www.chempartner.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Jacob Willam
Website ChemPartner
Country United States
Categories Business
Tags clinical epigenetics , antibody drug conjugates
Last Updated April 21, 2015